ReviewTransfusion medicine (Oxford, England)2026

Tocilizumab provides a potential therapeutic option for the management of hyperhaemolysis syndrome in sickle cell disease: A case series and brief narrative overview of the literature.

S Wolf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.